LBB Specialties LLC (LBBS), a North American distributor of specialty chemicals and ingredients providing technical solutions with a customer-first approach, has announced a new partnership with DMC Biotechnologies Inc. (DMC), a US-based ingredient supplier pioneering sustainable fermentation technologies.
Through this agreement, LBB Specialties will serve as the distributor of DMC’s “KeyPura” fermented myo-inositol and D-chiro-inositol in the United States and Canada — two next-generation ingredients produced through precision fermentation — serving the human nutrition, food, personal care, and Life Science markets.
This collaboration brings to market a cleaner, more sustainable, and more reliable source of inositols. As essential compounds, inositols play critical roles in hormonal balance, reproductive health, infant brain development, blood sugar regulation with improved insulin sensitivity, and overall metabolic health. DMC leverages their proprietary precision fermentation technology to produce bio-identical ingredients without solvents, with greater purity and consistency, and with a significantly lower environmental footprint than traditional chemical production methods, said Jerry Whelan, SVP, Food & Nutrition at LBBS.
Through precision fermentation and synthetic biology, DMC Biotechnologies creates sustainable, bio-based alternatives that reduce carbon emissions, enhance ingredient quality, and strengthen global supply chain resilience.
The company’s proprietary platform, “Dynamic Metabolic Control”, simplifies biological processes to enable predictable, scalable, and highly efficient fermentation—unlocking a new era of low-impact chemical manufacturing.
Together, LBBS and DMC are shaping the future of ingredient innovation. This partnership underscores our shared commitment to high-purity, naturally derived ingredients with proven health benefits – responsibly sourced and sustainably produced. The partnership further strengthens LBBS’s growing portfolio of functional and sustainable ingredient technologies that empower brands to meet the next generation of consumer expectations, without compromising performance, purity, or planet, said Rusty Pittman, VP of Business Development at DMC Biotechnologies.
